News

13/05/2025

The Sant Pau Research Institute Presents its New Strategic Plan 2025-2030

The Sant Pau Research Institute (IR Sant Pau) presented its new Strategic Plan 2025-2030 this Tuesday, in an event open to all research and healthcare staff. The plan will define the...

08/05/2025

Lipid Alterations Linked to Cardiovascular Risk Detected in People with Type 2 Diabetes

A recent study has identified specific alterations in lipid metabolism associated with subclinical atherosclerosis in individuals with type 2 diabetes. This silent condition, known as atherosclerosis,...

07/05/2025

Intravenous Administration of Atorvastatin Protects Against Infarction in the Presence of Diabetic Cardiomyopathy

Intravenous administration of atorvastatin during acute myocardial infarction could become a new therapeutic strategy capable of limiting infarct size in patients with diabetic cardiomyopathy, a heart...

30/04/2025

IR Sant Pau Strengthens Collaboration with Ephion Health and Joins the Startup’s Shareholding

The Sant Pau Research Institute (IR Sant Pau) has formalized a strategic agreement with Ephion Health, a company specialized in developing artificial intelligence technologies for monitoring mobility ...

29/04/2025

Over €100,000 raised for Ewing Sarcoma research at Sant Pau

In November 2023, the charity race L’Arriarem, organized by the family of Marc Riera i Castellà in his memory, raised over €96,000. Thanks to this momentum and all subsequent donations, €101,33...